Jade Biosciences, Inc. ( JBIO ) UBS Global Biopharma Conference 2026 November 16, 2026 7:00 AM EST
Company Participants
Tom Frohlich - President, CEO & Director
Andrew King - President of Research & Development
Conference Call Participants
Michael Yee - UBS Investment Bank, Research Division
Presentation
Michael Yee
UBS Investment Bank, Research Division
All right. I get to say good afternoon. It's 12:00. Thank you very much for being with us here at the UBS Biopharma Conference. I'm Michael Yee, Senior Biotechnology and Pharma analyst here at UBS. And very excited to have Jade Biosciences up here with us. That includes the CEO, Tom Frohlich; and President of Research and Development, Dr. Andrew King. Thank you, guys, for being here.
A lot going on in IgAN. And so I would love to turn it over to Tom, just briefly, you could give us an introduction to Jade Biosciences. You have a potential best-in-class APRIL inhibitor for the treatment of IgAN. There's a lot of competitors in this space.…